Pembrolizumab plus chemotherapy in triple-negative breast cancer – Authors' reply

  1. Cortes, J.
  2. Rugo, H.S.
  3. Guo, Z.
  4. Karantza, V.
  5. Schmid, P.
Journal:
The Lancet

ISSN: 1474-547X 0140-6736

Year of publication: 2021

Volume: 398

Issue: 10294

Pages: 24-25

Type: Letter

DOI: 10.1016/S0140-6736(21)00374-3 GOOGLE SCHOLAR lock_openOpen access editor